9MW3011 not checked

Mabwell

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
None yet
 
Trials
2 active
3 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Polycythemia Vera, Beta-Thalassemia
Main trialPhase 1
“The goal of this clinical trial is to assess the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of 9MW3011 in Chinese patients with Polycythemia Vera(PV).”In the company’s words, NCT06752746 on ClinicalTrials.gov

Other drugs for Polycythemia Vera

All 18 drugs for Polycythemia Vera

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials3

TrialPhaseCompletesWhat it tests
Phase 1Recruiting 31 Aug 2025 A Study of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of 9MW3011 in Patients With Polycythemia Vera
Phase 1Recruiting Oct 2026 A Multiple Ascending Dose Study of 9MW3011 in Patients With Non-transfusion-dependent β-thalassemia
Phase 1Completed 31 May 2024 Single Ascending Dose Study of 9MW3011 in Chinese Healthy Subject
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow 9MW3011

Following is part of Solo: you see every change to 9MW3011 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in